Medindia

X

Novel Model for Predicting Vaccine Efficacy and Safety

by Sheela Philomena on  May 15, 2012 at 2:24 PM Research News   - G J E 4
An innovative biomimetic model of the human immune system known as MIMIC® system has been developed by scientists. This model facilitates faster, more effective vaccine development.
 Novel Model for Predicting Vaccine Efficacy and Safety
Novel Model for Predicting Vaccine Efficacy and Safety
Advertisement

"Our goal is to increase the likelihood of success within the clinic- to make better drugs and vaccines and get them into the marketplace and to the patients faster," says William Warren, PhD, Head of the VaxDesign Campus, Sanofi Pasteur. "This in vitro human immune system enables us to measure vaccine efficacy earlier and more predictably."

Advertisement
The MIMIC® platform represents a truly disruptive technology for the study of vaccines and other biologics with immunomodulatory potential, as it provides a novel in vitro model for evaluating human immune responses against candidate drugs, adjuvants, and vaccines. It has shown game-changing advantages over conventional approaches to safety and efficacy testing.

Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All